CKS2 expression levels are also significantly up-regulated in patients with esophageal cancer (49), liver cancer (37) and adrenal cortical cancer (116), and abnormally high CKS2 expression is associated with poor prognosis of patients. Here, CKS2 is linked to esophageal cancer.